Insider track record Other Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Diana Conrad. Director active across 1 company, notably GSK plc. Cumulatively, 61 filings have been logged. History available since 12 October 2023. The latest transaction was disclosed on 14 April 2026 (Vesting). Regulator: RNS (LSE). The full history is openly available.
Companies and markets linked to Diana Conrad Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations 61 total
● Chief People Officer · Executives · 27 Apr 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:7106549c-e15c-42e1-8ae9-00c58e9dfb4b-1 ● Chief People Officer · Executives · 13 Apr 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:6f4b8128-9801-4594-b2e0-d87a4988fc21 ● Chief People Officer · Executives · 14 Apr 2026 · GSK plc 598 shares @ £21.67 0.0000% mcap 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-2 ● Chief People Officer · Executives · 13 Apr 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-21 ● Chief People Officer · Executives · 9 Apr 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:66208821-3d67-43ba-837e-411f45d449f1-6 ● Chief People Officer · Executives · 9 Apr 2026 · GSK plc 5 shares @ £21.338 0.0000% mcap 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:5b5d692c-e307-4a46-a436-f5464b4ee34b-2 ● Chief People Officer · Executives · 24 Mar 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:12ff8590-a7b5-4bd8-a0b1-007f4b5356fc-0 ● Chief People Officer · Executives · 30 Mar 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:12ff8590-a7b5-4bd8-a0b1-007f4b5356fc-1 ● Chief People Officer · Executives · 16 Mar 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:2f50fede-cb92-4465-ac31-b8f44859ddf6 ● Chief People Officer · Executives · 2 Mar 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:7b04616c-18bf-44f0-9bc8-15674e5c0310 ● Chief People Officer · Executives · 13 Feb 2026 · GSK plc 0
ISIN ISIN US37733W2044RNS:65d53a21-df91-48a4-b8d9-e4628530d4f4 ● Chief People Officer · Executives · 13 Feb 2026 · GSK plc 54,951 shares @ £21.6002 13.8% of flow ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-5 ● Chief People Officer · Executives · 13 Feb 2026 · GSK plc 102,653 shares 0
ISIN ISIN GB00BN7SWP63RNS:9e068048-67e6-4a53-8636-ebe7180e6da4-4 ● Chief People Officer · Executives · 12 Feb 2026 · GSK plc 15,984 shares @ £21.50 4.0% of flow ISIN ISIN GB00BN7SWP63RNS:6207777f-2477-470b-868f-21f92714189a-2 ● Chief People Officer · Executives · 9 Feb 2026 · GSK plc 25,742 shares 0
ISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-2 ● Chief People Officer · Executives · 9 Feb 2026 · GSK plc 10,000 shares @ £59.1802 0.1% of flow ISIN ISIN US37733W2044RNS:f7024c14-f781-4e48-a904-495085bc7ca2-9 ● Chief People Officer · Executives · 9 Feb 2026 · GSK plc 13,801 shares @ £22.0162 3.5% of flow ISIN ISIN GB00BN7SWP63RNS:527591f3-f598-44b4-87bb-f5cfd91a36cb-3 ● Chief People Officer · Executives · 9 Jan 2026 · GSK plc 686 shares @ £18.91 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-26 ● Chief People Officer · Executives · 8 Jan 2026 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-11 ● Chief People Officer · Executives · 8 Jan 2026 · GSK plc 4 shares @ £18.9425 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-2 ● Chief People Officer · Executives · 10 Oct 2025 · GSK plc 784 shares @ £16.40 0.2% of flow ISIN ISIN GB00BN7SWP63RNS:5862277-2 ● Chief People Officer · Executives · 9 Oct 2025 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:5859068-14 ● Chief People Officer · Executives · 9 Oct 2025 · GSK plc 5 shares @ £16.392 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:5859068-1 ● Chief People Officer · Executives · 11 Jul 2025 · GSK plc 0
ISIN ISIN GB00BN7SWP63RNS:5739159-5 ● Chief People Officer · Executives · 10 Jul 2025 · GSK plc 5 shares @ £14.444 0.0% of flow ISIN ISIN GB00BN7SWP63RNS:5737340-10 25 of 61 declarations
Load more (36 remaining) About Diana Conrad Diana Conrad is Chief People Officer at GSK plc (XLON). She has 52 filings in total, and across the sampled recent filings, purchases total EUR 994 and sales total EUR 4,498,499, between 2023-10-13 and 2026-04-16. The modal transaction nature is Purchase.